Atea Pharmaceuticals
Utility Patent Applications

Last updated:

List of all Atea Pharmaceuticals patents 13 in total

Status Patent
Application
Utility: BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTI- TUTED PURINE NUCLEOTIDES FOR HCV TREATMENT External link
Filling date: 26 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS External link
Filling date: 26 Sep 2025 Issue date: 9 Sep 2021
Application
Utility: HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19 External link
Filling date: 26 Sep 2025 Issue date: 9 Sep 2021
Application
Utility: NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS External link
Filling date: 26 Sep 2025 Issue date: 25 Mar 2021
Application
Utility: TREATMENT OF HCV INFECTED PATIENTS WITH CIRRHOSIS External link
Filling date: 26 Sep 2025 Issue date: 21 Jan 2021
Application
Utility: Beta-D-2'-DEOXY-2'-Alpha-FLUORO-2'-Beta-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTI- TUTED PURINE NUCLEOTIDES FOR HCV TREATMENT External link
Filling date: 26 Sep 2025 Issue date: 14 Jan 2021
Application
Utility: BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTI- TUTED PURINE NUCLEOTIDES FOR HCV TREATMENT External link
Filling date: 26 Sep 2025 Issue date: 22 Oct 2020
Application
Utility: BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTI- TUTED PURINE NUCLEOTIDES FOR HCV TREATMENT External link
Filling date: 26 Sep 2025 Issue date: 22 Oct 2020
Application
Utility: NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS External link
Filling date: 26 Sep 2025 Issue date: 22 Oct 2020
Application
Utility: Beta-D-2'-DEOXY-2'-Alpha-FLUORO-2'-Beta-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTI- TUTED PURINE NUCLEOTIDES FOR HCV TREATMENT External link
Filling date: 26 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: 2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREATMENT External link
Filling date: 26 Sep 2025 Issue date: 16 Jul 2020
Application
Utility: HIGHLY ACTIVE DRUG COMBINATION FOR TREATMENT OF HEPATITIS C VIRUS External link
Filling date: 26 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS External link
Filling date: 26 Sep 2025 Issue date: 19 Mar 2020

Showing 1 to 13 of 13 patents.